about
Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheresDendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content.Physiologically based pharmacokinetic modeling of nanoparticles.Physiologically based pharmacokinetic modeling for nanoparticle toxicity study.Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications.Delineating intracellular pharmacokinetics of paclitaxel delivered by PLGA nanoparticles.Rapid lymph accumulation of polystyrene nanoparticles following pulmonary administration.Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration.Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis.Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers.Terminology matters: There is no targeting, but retention.Quantitative nanoparticle organ disposition by gel permeation chromatography.Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine?Mathematical modelling of nanoparticle biodistribution: extrapolation among intravenous, oral and pulmonary administration routesNanotechnology-Based Biomarker DetectionCellular Uptake, Intracellular Trafficking, and Stability of Biocompatible Metal-Organic Framework (MOF) Particles in Kupffer CellsRole of Endocytosis in Nanoparticle Penetration of 3D Pancreatic Cancer SpheroidsBioadhesive Food Protein Nanoparticles as Pediatric Oral Drug Delivery SystemMetal Organic Framework (MOF) Particles as Potential Bacteria-Mimicking Delivery Systems for Infectious Diseases: Characterization and Cellular Internalization in Alveolar MacrophagesIntraductal Drug Delivery to the Breast: Effect of Particle Size and Formulation on Breast Duct and Lymph Node Retention
P50
Q33792946-8F4BC655-3DC3-4EBE-8B95-1AFD9F9184EEQ34901313-5D1A5DE6-7DB3-4DE8-9F01-E3A29BA06B2EQ35150539-E1D57315-3513-4923-B0A3-E0D3A110D6A0Q35822288-B29F1178-2F47-44A8-A372-3E3CF5380C9CQ37800093-B92453D4-FDFC-4A84-99C0-1C4BCF6F27B7Q38043339-84BE8BC7-7214-4540-9DF7-698607C797FAQ39381064-2E3E977F-D697-4315-8BAB-C901154F4875Q41197681-51178A31-0BD0-43BF-9D9A-B247C933A75BQ43479974-2DC2524F-A691-4E2E-9691-EE0BDF3BD747Q43877688-AB842912-DFF8-46BF-9B17-CD52A17C59BEQ45035342-3C26CB65-394A-4CEB-82C6-086A58FCC7B9Q48334631-A0636042-0D95-405D-87F2-F1E486B89B32Q49841410-E2021D7C-0AD1-4C6E-981C-836568A83986Q51323648-10C9A069-B6EF-446A-8BCB-3BAB70E77176Q60109943-185EB53C-3FB8-473F-AF9F-76003B843731Q60109972-6603654B-1EC0-4C99-8E5B-13FA1C42F5AAQ60109982-C5413D72-BAE3-448B-B31F-2D5339849895Q90225419-1AB7FDE2-9803-4713-BE3A-AF15F161EF1FQ91304595-6FF1C8B9-DDAA-4581-88DC-9DF698422B95Q91594716-679A13B2-CAE5-4BAF-81FF-E844EB952F50Q91796316-3D41AF07-8D27-432A-BE14-665DF7AD4952Q92316891-1499434B-ABDD-4DC4-9EB8-854157F2BDA4
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1788-862X
@en
name
Joshua Reineke
@ast
Joshua Reineke
@en
Joshua Reineke
@es
Joshua Reineke
@nl
type
label
Joshua Reineke
@ast
Joshua Reineke
@en
Joshua Reineke
@es
Joshua Reineke
@nl
prefLabel
Joshua Reineke
@ast
Joshua Reineke
@en
Joshua Reineke
@es
Joshua Reineke
@nl
P108
P106
P31
P496
0000-0002-1788-862X